A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor

PHASE2UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

September 30, 2021

Conditions
Advanced Malignant Tumor
Interventions
DRUG

TQ-B3101

TQ-B3101 is a ALK inhibitor.

Trial Locations (36)

100021

NOT_YET_RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

100071

NOT_YET_RECRUITING

The Fifth Medical Center of PLA Ceneral Hospital, Beijing

102218

NOT_YET_RECRUITING

Beijing Tsinghua Changgung Hospital, Beijing

116027

NOT_YET_RECRUITING

The Second Hospital of Dalian Medical University, Dalian

150000

NOT_YET_RECRUITING

Harbin Medical University Cancer Hospital, Harbin

200030

RECRUITING

Shanghai Jiaotong University Affiliated Chest Hospital, Shanghai

200080

NOT_YET_RECRUITING

Shanghai General Hospital, Shanghai

210000

NOT_YET_RECRUITING

Jiangsu Province Hospital, Nanjing

NOT_YET_RECRUITING

Nanjing First Hospital, Nanjing

230022

NOT_YET_RECRUITING

Anhui Chest Hospital, Hefei

230601

NOT_YET_RECRUITING

The Second Hospital of Anhui medical University, Hefei

264400

NOT_YET_RECRUITING

Weihai Central Hospital, Weihai

300052

NOT_YET_RECRUITING

Tianjin Medical University General Hospital, Tianjin

300060

NOT_YET_RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

310016

RECRUITING

Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou

310022

NOT_YET_RECRUITING

Zhejiang Cancer Hospital, Hangzhou

350011

NOT_YET_RECRUITING

Fujian Provincial Cancer Hospital, Fuzhou

410006

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

430079

NOT_YET_RECRUITING

Hubei Cancer Hospital, Wuhan

441099

NOT_YET_RECRUITING

Xiangyang First People's Hospital, Xiangyang

450003

NOT_YET_RECRUITING

Henan Provincial People's Hospital, Zhengzhou

450008

NOT_YET_RECRUITING

Henan Cancer Hospital, Zhengzhou

455000

NOT_YET_RECRUITING

AnYang Tumor Hospital, Anyang

471009

NOT_YET_RECRUITING

Luoyang Central Hospital Affiliated to Zhenghzou University, Luoyang

473000

NOT_YET_RECRUITING

Nanyang First People's Hospital, Nanyang

501195

NOT_YET_RECRUITING

Cancer Center of Guangzhou Medical University, Guangzhou

510120

NOT_YET_RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

545006

NOT_YET_RECRUITING

Liuzhou People's Hospital, Liuzhou

710038

NOT_YET_RECRUITING

The Second Affiliated Hospital of PLA Air Force Military Medical University, Xi’an

710061

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

710100

NOT_YET_RECRUITING

Xi'an Chest Hospital, Xi’an

830011

NOT_YET_RECRUITING

First Affiliated Hospital of Xinjiang Medical University, Ürümqi

NOT_YET_RECRUITING

The Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi

832000

NOT_YET_RECRUITING

First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi

844000

NOT_YET_RECRUITING

The First People's Hospital of Kashgar Prefecture, Kashgar Prefecture

030000

NOT_YET_RECRUITING

Shanxi Bethuen Hospital, Taiyuan

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY